RecruitingNCT04707781
Database for Interstitial Lung Disease
Clinical Database for the Early Recognition of Pulmonary Parenchymal Involvement in Patients With Systemic Diseases Bearing a Risk for Interstitial Lung Disease
Sponsor
Medical University of Graz
Enrollment
412 participants
Start Date
May 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age: ≥ 18 years
- patients with a known systemic disease bearing a risk for ILD
- signed informed consent (for prospective part)
Exclusion Criteria2
- Age \< 18 years
- comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTchest CT
assessment of interstitial lung disease using chest CT
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04707781
Related Trials
NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases
NCT057223401 location
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
NCT06572384131 locations
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
NCT063256961 location
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
NCT073729891 location
Cough Capture as a Portal Into the Lung
NCT058545631 location